Autor: "Liu, T." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Rate Versus Rhythm Control for Atrial Fibrillation.
Autorzy:: Shin ED; Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
Tran HN; Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA, USA.
Ramalingam ND; Graduate Medical Education, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
Liu T; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA, USA.; Department of Cardiac Electrophysiology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA, USA.
Fan E; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA, USA.; Department of Cardiology, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.; Pokaż więcej
Źródło:: The Permanente journal [Perm J] 2024 Mar 15; Vol. 28 (1), pp. 81-85. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Fibrillation*/complications
Atrial Fibrillation*/therapy
Heart Failure*/chemically induced
Humans ; Adult ; Anti-Arrhythmia Agents/therapeutic use ; Heart Rate ; Electric Countershock

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Iron and atrial fibrillation: A review.
Autorzy:: Ju H; Department of Cardiology, Remin Hospital of Wuhan University, Wuhan, China.
Liu T; Department of Cardiology, Remin Hospital of Wuhan University, Wuhan, China.
Yang M; Department of Cardiology, Remin Hospital of Wuhan University, Wuhan, China.
Cheng M; Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Wu G; Department of Cardiology, Remin Hospital of Wuhan University, Wuhan, China.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2023 Apr; Vol. 46 (4), pp. 312-318. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Atrial Fibrillation*
Atrial Remodeling*
Humans ; Iron/therapeutic use ; Heart Atria ; Disease Progression ; Calcium/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Role of Heat Shock Proteins in Atrial Fibrillation: From Molecular Mechanisms to Diagnostic and Therapeutic Opportunities.
Autorzy:: Liu D; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Han X; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Zhang Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Tse G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.; Cardiac Electrophysiology Unit, Cardiovascular Analytics Group, Hong Kong, China.; Kent and Medway Medical School, Canterbury CT2 7NZ, UK.
Shao Q; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.; Pokaż więcej
Źródło:: Cells [Cells] 2022 Dec 30; Vol. 12 (1). Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Heat-Shock Proteins*/metabolism
Atrial Fibrillation*/diagnosis
Humans ; HSP70 Heat-Shock Proteins/metabolism ; Heat-Shock Response ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Multi-parametric system for risk stratification in mitral regurgitation: A multi-task Gaussian prediction approach.
Autorzy:: Tse G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Zhou J; School of Data Science, City University of Hong Kong, Kowloon, Hong Kong SAR, China.
Lee S; Laboratory of Cardiovascular Physiology, Li Ka Shing Institute of Health Sciences, Hong Kong S.A.R., China.
Liu Y; Department of Anaesthesia and Intensive Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong S.A.R., China.
Leung KSK; Aston Medical School, Aston University, Birmingham, UK.
Lai RWC; Laboratory of Cardiovascular Physiology, Li Ka Shing Institute of Health Sciences, Hong Kong S.A.R., China.
Burtman A; Department of Epidemiology and Biostatistics, University of Arizona, Tucson, AZ, USA.
Wilson C; Department of Biology, University of Calgary, Calgary, Canada.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Li KHC; Faculty of Medicine, Newcastle University, Newcastle, UK.
Lakhani I; Department of Anaesthesia and Intensive Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong S.A.R., China.
Zhang Q; School of Data Science, City University of Hong Kong, Kowloon, Hong Kong SAR, China.; Pokaż więcej
Źródło:: European journal of clinical investigation [Eur J Clin Invest] 2020 Nov; Vol. 50 (11), pp. e13321. Date of Electronic Publication: 2020 Aug 11.
Typ publikacji:: Journal Article
MeSH Terms:: Mortality*
Atrial Fibrillation/*epidemiology
Heart Failure/*epidemiology
Interatrial Block/*physiopathology
Mitral Valve Insufficiency/*physiopathology
Stroke/*epidemiology
Aged ; Aged, 80 and over ; Blood Pressure ; Cause of Death ; Comorbidity ; Diabetes Mellitus/epidemiology ; Echocardiography ; Electrocardiography ; Female ; Humans ; Hypercholesterolemia/epidemiology ; Hypertension/epidemiology ; Interatrial Block/epidemiology ; Ischemic Attack, Transient/epidemiology ; Leukocyte Count ; Lymphocyte Count ; Lymphocytes ; Male ; Middle Aged ; Mitral Valve Insufficiency/blood ; Mitral Valve Insufficiency/diagnostic imaging ; Mitral Valve Insufficiency/epidemiology ; Myocardial Ischemia/epidemiology ; Neutrophils ; Nutrition Assessment ; Pulmonary Artery ; Risk Assessment ; Stroke Volume

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Identification of Circular RNA-MicroRNA-Messenger RNA Regulatory Network in Atrial Fibrillation by Integrated Analysis.
Autorzy:: Liu T; Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Zhang G; Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Wang Y; Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Rao M; Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Zhang Y; Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Guo A; Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.
Wang M; Department of Cardiology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2020 Sep 29; Vol. 2020, pp. 8037273. Date of Electronic Publication: 2020 Sep 29 (Print Publication: 2020).
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Fibrillation*/genetics
Atrial Fibrillation*/metabolism
RNA*/genetics
RNA*/metabolism
Aged, 80 and over ; Cardiomyopathies/genetics ; Cardiomyopathies/metabolism ; Computational Biology ; Gene Regulatory Networks/genetics ; Humans ; Signal Transduction/genetics ; Transcriptome/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
Autorzy:: Shao Q; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Meng L; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Lee S; Laboratory of Cardiovascular Physiology, Li Ka Shing Institute of Health Sciences, Sha Tin, Hong Kong S.A.R., China.
Tse G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Gong M; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Zhang Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Zhao J; Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.
Zhao Y; Tianjin Key Laboratory of Exercise Physiology and Sports Medicine, Department of Health & Exercise Science, Tianjin University of Sport, Tianjin, 300381, People's Republic of China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China. tic_.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China. .; Pokaż więcej
Źródło:: Cardiovascular diabetology [Cardiovasc Diabetol] 2019 Nov 28; Vol. 18 (1), pp. 165. Date of Electronic Publication: 2019 Nov 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Fibrillation/*prevention & control
Atrial Function, Left/*drug effects
Atrial Remodeling/*drug effects
Benzhydryl Compounds/*pharmacology
Diabetes Mellitus, Experimental/*drug therapy
Diabetes Mellitus, Type 2/*drug therapy
Glucosides/*pharmacology
Heart Rate/*drug effects
Mitochondria, Heart/*drug effects
Sodium-Glucose Transporter 2 Inhibitors/*pharmacology
Animals ; Atrial Fibrillation/etiology ; Atrial Fibrillation/metabolism ; Atrial Fibrillation/physiopathology ; Diabetes Mellitus, Experimental/etiology ; Diabetes Mellitus, Experimental/metabolism ; Diabetes Mellitus, Experimental/physiopathology ; Diabetes Mellitus, Type 2/etiology ; Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/physiopathology ; Diet, High-Fat ; Disease Models, Animal ; Male ; Membrane Potential, Mitochondrial/drug effects ; Mitochondria, Heart/metabolism ; Mitochondrial Proteins/metabolism ; Organelle Biogenesis ; Oxidative Stress/drug effects ; Rats, Sprague-Dawley ; Signal Transduction ; Streptozocin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The relationship between red blood cell distribution width and atrial fibrillation in Asian population: A cross-sectional study.
Autorzy:: Li H; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Gu Y; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Liu M; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Wang X; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Chi VTQ; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Zhang Q; Health Management Centre, Tianjin Medical University General Hospital, Tianjin, China.
Liu L; Health Management Centre, Tianjin Medical University General Hospital, Tianjin, China.
Meng G; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Yao Z; Tianjin Institute of Environmental & Operational Medicine, Tianjin, China.
Wu H; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Bao X; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Zhang S; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Kumari S; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Sun S; Health Management Centre, Tianjin Medical University General Hospital, Tianjin, China.
Zhou M; Health Management Centre, Tianjin Medical University General Hospital, Tianjin, China.
Jia Q; Health Management Centre, Tianjin Medical University General Hospital, Tianjin, China.
Song K; Health Management Centre, Tianjin Medical University General Hospital, Tianjin, China.
Wu Y; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.
Liu T; Department of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Niu K; Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin, China.; Health Management Centre, Tianjin Medical University General Hospital, Tianjin, China.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2019 Sep; Vol. 42 (9), pp. 1197-1203. Date of Electronic Publication: 2019 Aug 20.
Typ publikacji:: Journal Article
MeSH Terms:: Erythrocyte Indices*
Atrial Fibrillation/*blood
Atrial Fibrillation/*epidemiology
Adult ; Asian People ; Cross-Sectional Studies ; Female ; Humans ; Male ; Prevalence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Oxidative stress and atrial fibrillation: an update.
Autorzy:: Korantzopoulos P; a First Department of Cardiology , University of Ioannina Medical School , Ioannina , Greece.
Letsas K; b Second Department of Cardiology, Laboratory of Cardiac Electrophysiology , 'Evangelismos' General Hospital of Athens , Athens , Greece.
Fragakis N; c Third Department of Cardiology , Hippokration Hospital, Medical School, Aristotle University of Thessaloniki , Thessaloniki , Athens , Greece.
Tse G; d Department of Medicine and Therapeutics , Chinese University of Hong Kong , Hong Kong , P. R. China.; e Li Ka Shing Institute of Health Sciences, Faculty of Medicine , Chinese University of Hong Kong , Hong Kong , China.
Liu T; f Department of Cardiology , Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University , Tianjin , P. R. China.; Pokaż więcej
Źródło:: Free radical research [Free Radic Res] 2018 Dec; Vol. 52 (11-12), pp. 1199-1209. Date of Electronic Publication: 2018 Sep 10.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Oxidative Stress*
Atrial Fibrillation/*metabolism
Animals ; Antioxidants/metabolism ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Upstream therapeutic strategies of valsartan and fluvastatin on hypertensive patients with non-permanent atrial fibrillation.
Autorzy:: Zhao Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Niu X; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Dong Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Qi W; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Liu E; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Li L; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Liang Y; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; Pokaż więcej
Źródło:: Cardiovascular therapeutics [Cardiovasc Ther] 2018 Dec; Vol. 36 (6), pp. e12478. Date of Electronic Publication: 2018 Nov 28.
Typ publikacji:: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Anti-Arrhythmia Agents/*therapeutic use
Antihypertensive Agents/*therapeutic use
Atrial Fibrillation/*drug therapy
Fluvastatin/*therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Hypertension/*drug therapy
Valsartan/*therapeutic use
Aged ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Anti-Arrhythmia Agents/adverse effects ; Antihypertensive Agents/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Atrial Fibrillation/physiopathology ; Blood Pressure/drug effects ; China/epidemiology ; Disease Progression ; Female ; Fluvastatin/adverse effects ; Heart Rate/drug effects ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Hypertension/diagnosis ; Hypertension/epidemiology ; Hypertension/physiopathology ; Incidence ; Male ; Middle Aged ; Prospective Studies ; Recurrence ; Time Factors ; Treatment Outcome ; Valsartan/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The incidence of atrial fibrillation with trastuzumab treatment: A systematic review and meta-analysis.
Autorzy:: Yuan M; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Tse G; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, SAR, China.; Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, SAR, China.
Zhang Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Han X; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Wu WKK; Department of Anaesthesia and Intensive Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Xia Y; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; Pokaż więcej
Źródło:: Cardiovascular therapeutics [Cardiovasc Ther] 2018 Dec; Vol. 36 (6), pp. e12475. Date of Electronic Publication: 2018 Nov 28.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Antineoplastic Agents, Immunological/*adverse effects
Atrial Fibrillation/*chemically induced
Atrial Fibrillation/*epidemiology
Breast Neoplasms/*drug therapy
Trastuzumab/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Atrial Fibrillation/diagnosis ; Breast Neoplasms/diagnosis ; Breast Neoplasms/epidemiology ; Breast Neoplasms, Male/diagnosis ; Breast Neoplasms, Male/drug therapy ; Breast Neoplasms, Male/epidemiology ; Cardiotoxicity ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Reactive oxygen species mediated oxidative stress links diabetes and atrial fibrillation.
Autorzy:: Liang X; Tianjin Key Laboratory of Ionic‑Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Zhang Q; Tianjin Key Laboratory of Ionic‑Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Wang X; Tianjin Key Laboratory of Ionic‑Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Yuan M; Tianjin Key Laboratory of Ionic‑Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Zhang Y; Tianjin Key Laboratory of Ionic‑Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Xu Z; Tianjin Key Laboratory of Ionic‑Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Li G; Tianjin Key Laboratory of Ionic‑Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Liu T; Tianjin Key Laboratory of Ionic‑Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.; Pokaż więcej
Źródło:: Molecular medicine reports [Mol Med Rep] 2018 Apr; Vol. 17 (4), pp. 4933-4940. Date of Electronic Publication: 2018 Jan 24.
Typ publikacji:: Journal Article
MeSH Terms:: Oxidative Stress*
Atrial Fibrillation/*etiology
Atrial Fibrillation/*metabolism
Diabetes Mellitus/*metabolism
Reactive Oxygen Species/*metabolism
Animals ; Biomarkers ; Cell Proliferation ; Fibroblasts/metabolism ; Heart Atria/metabolism ; MAP Kinase Signaling System ; Male ; Matrix Metalloproteinases/metabolism ; NADPH Oxidases/genetics ; NADPH Oxidases/metabolism ; Rabbits ; Vimentin/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Prolonged corrected QT interval in predicting atrial fibrillation: A systematic review and meta-analysis.
Autorzy:: Zhang N; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, P.R. China.
Gong M; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, P.R. China.
Tse G; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, SAR, P.R. China.; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, SAR, P.R. China.; School of Health Sciences, University of Manchester, Manchester, United Kingdom.
Zhang Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, P.R. China.
Meng L; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, P.R. China.
Yan BP; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, SAR, P.R. China.; Department of Epidemiology and Preventive Medicine, Monash University, Clayton, VIC, Australia.
Zhang L; Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, P.R. China.
Wu G; Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, Hubei, P.R. China.
Xia Y; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, P.R. China.
Xin-Yan G; Lankenau Institute for Medical Research and Lankenau Medical Center, Wynnewood, PA, USA.; Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, P.R. China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, P.R. China.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2018 Mar; Vol. 41 (3), pp. 321-327. Date of Electronic Publication: 2018 Feb 16.
Typ publikacji:: Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:: Atrial Fibrillation/*diagnosis
Atrial Fibrillation/*etiology
Long QT Syndrome/*complications
Long QT Syndrome/*diagnosis
Atrial Fibrillation/physiopathology ; Electrocardiography ; Humans ; Long QT Syndrome/physiopathology ; Predictive Value of Tests ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Low-voltage areas detected by high-density electroanatomical mapping predict recurrence after ablation for paroxysmal atrial fibrillation.
Autorzy:: Vlachos K; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Efremidis M; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Letsas KP; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Bazoukis G; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Martin R; Newcastle University, Newcastle, UK.
Kalafateli M; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Lioni L; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Georgopoulos S; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Saplaouras A; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Efremidis T; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
Valkanas K; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Karamichalakis N; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Asvestas D; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Sideris A; Laboratory of Cardiac Electrophysiology, Second Department of Cardiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.; Pokaż więcej
Źródło:: Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2017 Dec; Vol. 28 (12), pp. 1393-1402. Date of Electronic Publication: 2017 Sep 08.
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Fibrillation/*diagnostic imaging
Atrial Fibrillation/*physiopathology
Body Surface Potential Mapping/*methods
Catheter Ablation/*methods
Imaging, Three-Dimensional/*methods
Aged ; Atrial Fibrillation/surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prospective Studies ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits.
Autorzy:: Liu C; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Liu R; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Fu H; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Li J; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Wang X; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Cheng L; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Korantzopoulos P; First Department of Cardiology, University of Ioannina Medical School, Ioannina, Greece.
Tse G; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China.; Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; Pokaż więcej
Źródło:: Cardiovascular therapeutics [Cardiovasc Ther] 2017 Oct; Vol. 35 (5).
Typ publikacji:: Journal Article
MeSH Terms:: Alloxan*
Atrial Fibrillation/*prevention & control
Atrial Remodeling/*drug effects
Diabetes Mellitus, Experimental/*drug therapy
Heart Rate/*drug effects
Hypoglycemic Agents/*pharmacology
PPAR gamma/*agonists
Thiazolidinediones/*pharmacology
Action Potentials/drug effects ; Animals ; Atrial Fibrillation/etiology ; Atrial Fibrillation/metabolism ; Atrial Fibrillation/physiopathology ; Diabetes Mellitus, Experimental/chemically induced ; Diabetes Mellitus, Experimental/metabolism ; Fibrosis ; HSP70 Heat-Shock Proteins/metabolism ; Mitogen-Activated Protein Kinase 1/metabolism ; NF-kappa B p50 Subunit/metabolism ; PPAR gamma/metabolism ; Phosphorylation ; Pioglitazone ; Rabbits ; Signal Transduction/drug effects ; Toll-Like Receptor 4/metabolism ; Transforming Growth Factor beta1/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Neural substrate of posterior left atrium: A novel modulation for inducibility and remodeling of atrial fibrillation in canine.
Autorzy:: Qin M; Department of Cardiology, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China.
Li L; Department of Cardiology, the First College of Clinical Medical Sciences, China Three Gorges University, Yichang, China.
Liu X; Department of Cardiology, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China.
Liu T; Cardiovascular Research Institute of Wuhan University, Wuhan, China.
Shi SB; Cardiovascular Research Institute of Wuhan University, Wuhan, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2017 May 05; Vol. 12 (5), pp. e0176626. Date of Electronic Publication: 2017 May 05 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Remodeling*
Atrial Fibrillation/*veterinary
Dog Diseases/*physiopathology
Vagus Nerve/*physiopathology
Animals ; Atrial Fibrillation/physiopathology ; Dogs ; Male

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression.
Autorzy:: Qi W; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; School of Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang N; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Korantzopoulos P; First Department of Cardiology, University of Ioannina Medical School, Ioannina, Greece.
Letsas KP; Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Cheng M; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Di F; Department of Endocrinology and Metabolism, the Third Central Hospital of Tianjin, Tianjin, China.
Tse G; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, Special Administrative Region, P.R. China.; Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, Special Administrative Region, P.R. China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2017 Mar 07; Vol. 12 (3), pp. e0170955. Date of Electronic Publication: 2017 Mar 07 (Print Publication: 2017).
Typ publikacji:: Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:: Glycated Hemoglobin*
Atrial Fibrillation/*blood
Atrial Fibrillation/*diagnosis
Atrial Fibrillation/epidemiology ; Biomarkers ; Humans ; Odds Ratio ; Prognosis ; Publication Bias ; Risk Assessment

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.
Autorzy:: Hu B; Department of Cardiology, Zhongshan Affiliated Hospital of Sun Yat-sen University, Zhongshan, Guangdong, China.
Sun Y; Department of Cardiology, Zhongshan Affiliated Hospital of Sun Yat-sen University, Zhongshan, Guangdong, China.
Li S; Department of Laboratory Diagnosis, Zhongshan Affiliated Hospital of Sun Yat-sen University, Zhongshan, Guangdong, China.
Sun J; Department of Cardiology, Zhongshan Affiliated Hospital of Sun Yat-sen University, Zhongshan, Guangdong, China.
Liu T; Department of Cardiology, Zhongshan Affiliated Hospital of Sun Yat-sen University, Zhongshan, Guangdong, China.
Wu Z; Department of Cardiology, Zhongshan Affiliated Hospital of Sun Yat-sen University, Zhongshan, Guangdong, China.
Feng LI; Department of Cardiology, Zhongshan Affiliated Hospital of Sun Yat-sen University, Zhongshan, Guangdong, China.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2016 Dec; Vol. 39 (12), pp. 1379-1387. Date of Electronic Publication: 2016 Dec 07.
Typ publikacji:: Journal Article
MeSH Terms:: Atrial Fibrillation/*epidemiology
Atrial Fibrillation/*immunology
Autoantibodies/*immunology
Receptor, Muscarinic M2/*immunology
Atrial Fibrillation/blood ; Atrial Fibrillation/diagnosis ; Autoantibodies/blood ; Biomarkers/blood ; China/epidemiology ; Disease Progression ; Female ; Heart Valve Diseases/blood ; Heart Valve Diseases/epidemiology ; Heart Valve Diseases/immunology ; Humans ; Incidence ; Male ; Middle Aged ; Receptor, Muscarinic M2/blood ; Reproducibility of Results ; Risk Assessment ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Linear Ablation Following Pulmonary Vein Isolation in Patients with Atrial Fibrillation: A Meta-Analysis.
Autorzy:: Zhang Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
Letsas KP; Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Zhang N; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
Efremidis M; Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, 'Evangelismos' General Hospital of Athens, Athens, Greece.
Xu G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.; Pokaż więcej
Źródło:: Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2016 Jun; Vol. 39 (6), pp. 623-30. Date of Electronic Publication: 2016 Apr 18.
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Atrial Fibrillation/*surgery
Catheter Ablation/*methods
Pulmonary Veins/*surgery
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Association of Plasma Transforming Growth Factor-β1 Levels and the Risk of Atrial Fibrillation: A Meta-Analysis.
Autorzy:: Li J; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Yang Y; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Ng CY; Cardiac Arrhythmia Service, Massachusetts General Hospital, 55 Fruit St., Boston, Massachusetts, 02114, United States of America.
Zhang Z; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Li G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 May 12; Vol. 11 (5), pp. e0155275. Date of Electronic Publication: 2016 May 12 (Print Publication: 2016).
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Atrial Fibrillation/*blood
Transforming Growth Factor beta1/*blood
Atrial Fibrillation/epidemiology ; Confounding Factors, Epidemiologic ; Female ; Humans ; Male ; Multivariate Analysis ; Risk Factors ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.
Autorzy:: Qi WW; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, PR China. .
Liu T; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, PR China. .
Xu G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, PR China. xugang_.
Li LF; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, PR China. cardio_.
Liang YZ; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, PR China. .
Ye L; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, PR China. yelan_.
Li GP; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, PR China. .; Pokaż więcej
Źródło:: Trials [Trials] 2015 Aug 07; Vol. 16, pp. 336. Date of Electronic Publication: 2015 Aug 07.
Typ publikacji:: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Antihypertensive Agents/*therapeutic use
Atrial Fibrillation/*drug therapy
Blood Pressure/*drug effects
Fatty Acids, Monounsaturated/*therapeutic use
Heart Rate/*drug effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
Hypertension/*drug therapy
Indoles/*therapeutic use
Valsartan/*therapeutic use
Angiotensin II Type 1 Receptor Blockers/adverse effects ; Antihypertensive Agents/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/etiology ; Atrial Fibrillation/mortality ; Atrial Fibrillation/physiopathology ; China ; Clinical Protocols ; Electrocardiography, Ambulatory ; Fatty Acids, Monounsaturated/adverse effects ; Fluvastatin ; Heart Failure/etiology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Hypertension/complications ; Hypertension/diagnosis ; Hypertension/mortality ; Hypertension/physiopathology ; Indoles/adverse effects ; Myocardial Infarction/etiology ; Prospective Studies ; Recurrence ; Research Design ; Risk Assessment ; Risk Factors ; Shock, Cardiogenic/etiology ; Time Factors ; Treatment Outcome ; Valsartan/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Liu, T."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język